Table 1.
Demographic characteristics of the study population
| Characteristics | |
|---|---|
| Total population | 43 patients |
| M/F, n (%) | 28 (65.1)/15 (34.9) |
| Mean age, years (± SD) | 45.91 (± 15.8) |
| Mean BMI, kg/m2 (± SD) | 24.6 (± 3.5) |
| Median age at the onset of disease (25–75 percentile) | 6 (1–27) |
| Allergic rhinitis, n (%) | 15/43 (34.9) |
| Asthma, n (%) | 12/43 (27.9) |
| Allergic conjunctivitis, n (%) | 10/43 (23.3) |
| Chronic rhinosinusitis with nasal polyposis, n (%) | 1/43 (2.3) |
| Food allergy, n (%) | 10/43 (23.3) |
| Patients previously treated with CsA, n (%) | 42/43 (97.7) |
| Patients previously treated with dupilumab, n (%) | 42/43 (97.7) |
| Patients previously treated with methotrexate, n (%) | 20/43 (46.5) |
| Patients previously treated with oral corticosteroids, n (%) | 14/43 (42.4) |
| Patients previously treated with tralokinumab, n (%) | 2/43 (4.6) |
BMI body mass index, CsA cyclosporine, n number, SD standard deviation